Jump to main content
Jump to site search
SCHEDULED MAINTENANCE Close the message box

Maintenance work is planned for Monday 16 August 2021 from 07:00 to 23:59 (BST).

Website performance may be temporarily affected and you may not be able to access some PDFs or images. If this does happen, refreshing your web browser should resolve the issue. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 4, 2016

Phenolate based metallomacrocyclic xanthate complexes of CoII/CuII and their exclusive deployment in [2 : 2] binuclear N,O-Schiff base macrocycle formation and in vitro anticancer studies

Author affiliations

Abstract

Potassium salts of phenolate based polydentate xanthate ligands 4,4′-bis(2-dithiocarbonatobenzylideneamino)diphenyl ether (K2xan1) and 4,4′-bis(2-dithiocarbonatonaphthylmethylideneamino)diphenyl ether (K2xan2) have been synthesized and characterized, prior to use. The reaction of K2xan1 or K2xan2 with M(OAc)2 in Et3N affords access to a rare series of binuclear metallomacrocyclic xanthate complexes of the type [M22-bis-(κ2S,S-xan1/xan2)] (1–4) which quickly forms [2 : 2] binuclear N,O-bidentate Schiff base macrocyclic complexes of the type [M22-bis-(κ2N,O-L1/L2)] (L1 = 4,4′-bis(2-hydroxybenzylideneamino)diphenyl ether, L2 = 4,4′-bis(2-hydroxynaphthylmethylidene-amino)diphenyl ether) 5–8via evolution of CS2 in solution. The compounds were characterized by microanalysis, relevant spectroscopy (FT-IR, UV-visible), mass spectrometry (ESI-MS), and powder and single crystal XRD techniques. In vitro anticancer activity of all the compounds was evaluated against HEP 3B (hepatoma) and IMR 32 (neuroblastoma) by the MTT assay. Remarkably, the binuclear copper(II) xanthate complexes were found to be extremely active against both the cell lines (IC50: 8.1 ± 0.8 μM (3), 8.8 ± 1.7 μM (4) against HEP 3B and 1.9 ± 0.3 μM (3) and 7.3 ± 0.6 μM (4) against IMR 32) and this projects them as good candidates for potent antitumor agents and the IC50 values confirm their better potency than the reference drug cisplatin. The flow-cytometric density plot illustrates the induction of apoptosis in HEP 3B and IMR 32 cells after treatment with K2xan1, 1, 3, 6 and 7.

Graphical abstract: Phenolate based metallomacrocyclic xanthate complexes of CoII/CuII and their exclusive deployment in [2 : 2] binuclear N,O-Schiff base macrocycle formation and in vitro anticancer studies

Supplementary files

Article information


Submitted
02 Sep 2015
Accepted
30 Nov 2015
First published
02 Dec 2015

Dalton Trans., 2016,45, 1443-1454
Article type
Paper
Author version available

Phenolate based metallomacrocyclic xanthate complexes of CoII/CuII and their exclusive deployment in [2 : 2] binuclear N,O-Schiff base macrocycle formation and in vitro anticancer studies

V. K. Singh, R. Kadu, H. Roy, P. Raghavaiah and S. M. Mobin, Dalton Trans., 2016, 45, 1443 DOI: 10.1039/C5DT03407H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.


Social activity

Search articles by author

Spotlight

Advertisements